Skip to main content

Table 1 Part of the baseline characteristics of the population included in each group

From: Transcatheter mitral valve replacement for degenerated mitral valve bioprostheses, failure of mitral valvuloplasty and native valve with severe mitral annulus calcification: a systematic review and meta-analysis

Author

Nation

Year

Consecutive cases

Follow-up

Complete follow-up for 30-day

All patients

Age (years)

Female

ViV

ViR

ViMAC

ViV

ViR

ViMAC

ViV

ViR

ViMAC

Eleid [25]

US

2017

Yes

30-day and 1-year

Yes

60

15

12

75 ± 11

72 ± 8

79 ± 9

34

9

5

Yoon [20]

US

2018

Yes

1, 6, and 12 months and yearly thereafter

Yes

322

141

58

72.6 ± 12.9

71.7 ± 9.7

74.7 ± 10.8

189

52

41

Hu [26]

–

2018

NO

1and 6 months

No

172

73

 

74.5 ± 12.5

70.0 ± 10.8

 

61

21

 

Tiwana [27]

US

2020

Yes

30-day

Yes

 

12

28

 

74.1(71.1–77.4)

74.2(70–81.7)

 

8

22

Guerrero [28]

US

2020

unclear

30-day

No

680

123

100

76 (67–83)

73 (67–79)

77 (65–82.5)

407

59

69

Simonato [29]

US

2020

unclear

492 days

[IQR 76 – 996 days]

YES

857

222

 

74.1 ± 12.4

71.2 ± 12.8

 

530

109

Â